These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow. Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242 [TBL] [Abstract][Full Text] [Related]
4. Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy. Kiowski W; Erne P; Pfisterer M; Mueller J; Buehler FR; Burkart F Am J Cardiol; 1987 May; 59(12):1118-25. PubMed ID: 3578053 [TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of nilvadipine, a new dihydropyridine-type calcium antagonist. Honerjäger P; Seibel K J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S15-21. PubMed ID: 1283184 [TBL] [Abstract][Full Text] [Related]
6. Effects of a new second generation calcium channel blocker, nilvadipine (FR34235), on exercise-induced hemodynamic changes in stable angina pectoris. Yokota M; Koide M; Miyahara T; Kamihara S; Tsunekawa A; Noda S; Sotobata I J Am Coll Cardiol; 1987 Oct; 10(4):830-6. PubMed ID: 3655150 [TBL] [Abstract][Full Text] [Related]
7. Effects of nilvadipine on the cardiovascular system in experimental animals. Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of nisoldipine in chronic congestive heart failure. Vogt A; Kreuzer H Arzneimittelforschung; 1983; 33(6):877-9. PubMed ID: 6684444 [TBL] [Abstract][Full Text] [Related]
9. Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure. Kubo SH; Fox SC; Prida XE; Cody RJ Am Heart J; 1985 Nov; 110(5):1032-4. PubMed ID: 3933315 [TBL] [Abstract][Full Text] [Related]
10. Nilvadipine: profile of a new calcium antagonist. An overview. Rosenthal J J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101 [TBL] [Abstract][Full Text] [Related]
11. Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure. Elkayam U; Weber L; McKay CR; Rahimtoola SH Am J Cardiol; 1984 Jul; 54(1):126-31. PubMed ID: 6741802 [TBL] [Abstract][Full Text] [Related]
12. Forearm venous distensibility in relation to severity of symptoms and hemodynamic data in patients with congestive heart failure. Ikenouchi H; Iizuka M; Sato H; Momomura S; Serizawa T; Sugimoto T Jpn Heart J; 1991 Jan; 32(1):17-34. PubMed ID: 2038122 [TBL] [Abstract][Full Text] [Related]
13. Effect of the second-generation calcium channel blocker nisoldipine on left ventricular contractility in cardiac failure. Lewis BS; Shefer A; Merdler A; Flugelman MY; Hardoff R; Halon DA Am Heart J; 1988 Jun; 115(6):1238-44. PubMed ID: 3376841 [TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure. Koseki N; Araie M; Tomidokoro A; Nagahara M; Hasegawa T; Tamaki Y; Yamamoto S Ophthalmology; 2008 Nov; 115(11):2049-57. PubMed ID: 18672290 [TBL] [Abstract][Full Text] [Related]
15. Short-term and long-term hemodynamic and clinical effects of metoprolol alone and combined with amlodipine in patients with chronic heart failure. Kukin ML; Freudenberger RS; Mannino MM; Kalman J; Steinmetz M; Buchholz-Varley C; Ocampo ON Am Heart J; 1999 Aug; 138(2 Pt 1):261-8. PubMed ID: 10426837 [TBL] [Abstract][Full Text] [Related]
17. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure. Munger MA; Nara AR; Pospisil RA; Stoddard GJ; Schleman M Pharmacotherapy; 1993; 13(3):218-23. PubMed ID: 8100627 [TBL] [Abstract][Full Text] [Related]
18. Long-term clinical effect of nilvadipine in patients with chronic heart failure: a double-blind placebo-controlled study. Hori M; Sato H; Karita M; Kodama K; Hoki N; Hayashi T; Naka M; Nanto S; Yamada Y; Kamada T Heart Vessels; 1994; 9(5):249-53. PubMed ID: 7814301 [TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure. Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426 [TBL] [Abstract][Full Text] [Related]
20. [Comparison of the acute hemodynamic effect of nisoldipine (Bay k 5552) and nifedipine in patients with ischemia-induced left ventricular impaired function]. Aschenberg W; Nienaber C; Spielmann R; Bleifeld W Z Kardiol; 1988 Apr; 77(4):238-44. PubMed ID: 3291444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]